Related Experiment Video

Updated: Sep 14, 2026

Minimal Erythema Dose (MED) Testing
06:24

Minimal Erythema Dose (MED) Testing

Published on: May 28, 2013

Erythema nodosum in children: a prospective study

T Kakourou1, P Drosatou, F Psychou

  • 1First Department of Pediatrics, and the Department of Pathology, Athens University, Greece.

Insights

Erythema nodosum (EN) in children is often caused by infections, particularly beta-hemolytic streptococcus. While generally benign, Mycobacterium tuberculosis should be considered, and recurrences are rare.

Area of Science:

  • Pediatric Dermatology
  • Infectious Diseases
  • Rheumatology

Background:

  • Limited studies exist on pediatric erythema nodosum (EN), with most being retrospective.
  • Understanding the epidemiology and clinical course of EN in children is crucial.

Purpose of the Study:

  • To evaluate the epidemiology, etiology, clinical features, course, and prognosis of erythema nodosum in a pediatric cohort.
  • To identify common causes and outcomes of EN in children.

Main Methods:

  • A prospective study of 35 children diagnosed with erythema nodosum.
  • Exclusion of four children with biopsy-proven leukocytoclastic vasculitis or eosinophilic cellulitis.
  • Laboratory investigations to determine the etiology of EN.

Main Results:

  • Infectious agents were identified as the cause in 77% of cases, with beta-hemolytic streptococcus being the most frequent (n=17).
  • Mycobacterium tuberculosis, Crohn's disease, and Hodgkin's disease were less common etiologies.
  • The mean duration of the rash was 11.5 days, and recurrences were exceptional (2 children).

Conclusions:

  • Beta-hemolytic streptococcus is the predominant cause of EN in children in Greece.
  • Mycobacterium tuberculosis remains a significant consideration for pediatric EN.
  • Erythema nodosum in children typically follows a benign course with rare relapses.
Abstract

Related Concept Videos